NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Vaccine Adjuvant Clinical Evaluation

The find of COVID-19 vaccine: Challenges and opportunities

Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and

Controlled Human Infection Models To Accelerate Vaccine

News - VaccineNation

Vaccine Adjuvant Discovery and Mechanistic Research

Controlled Human Infection Models To Accelerate Vaccine

Adjuvant Development Program NIAID: National Institute of

Intestinal helminth infection impairs oral and parenteral vaccine

Vaccines platforms and COVID-19: what you need to know

NIAID workshop on secondary vaccine effects